Literature DB >> 18004133

Clozapine and olanzapine are associated with food craving and binge eating: results from a randomized double-blind study.

Michael Kluge1, Andreas Schuld, Hubertus Himmerich, Mira Dalal, Alexander Schacht, Peter M Wehmeier, Dunja Hinze-Selch, Thomas Kraus, Ralf W Dittmann, Thomas Pollmächer.   

Abstract

The second generation antipsychotics clozapine and olanzapine frequently induce weight gain. Randomized studies investigating abnormal eating behavior (food craving, binge eating) possibly associated with weight gain are lacking. Thirty patients with schizophrenia, schizophreniform, or schizoaffective disorder were included in this randomized, double-blind, parallel study comparing abnormal eating behavior using a standardized scale, clinical efficacy using the Brief Psychiatric Rating Scale 0-6 and Clinical Global Impression-Severity scale, and tolerability of clozapine and olanzapine. In both treatment groups, the number of patients reporting food craving, binge eating, or both increased over time. The likelihood to experience food craving at any time during drug treatment showed a trend (P = 0.068) to be higher in the olanzapine group (48.9%) compared with the clozapine group (23.3%). The likelihood to experience binge eating at any time during drug treatment was numerically but not statistically significantly higher in the olanzapine group (16.7%) than in the clozapine group (8.9%). In both groups, significant baseline-to-end point improvements of clinical symptoms (Brief Psychiatric Rating Scale 0-6: clozapine, 36.6 +/- 8.8 to 15.9 +/- 13.7; olanzapine, 36.7 +/- 9.9 to 19.1 +/- 13.8) and severity of illness (Clinical Global Impression-Severity scale: clozapine, 4.7 +/- 0.6 to 2.5 +/- 1.5; olanzapine, 4.5 +/- 0.6 to 2.3 +/- 1.2) were observed. These improvements did not differ significantly between groups. Olanzapine was more tolerable than clozapine; adverse events occurred significantly (P < 0.01) less frequently than in the clozapine group. These results suggest that both clozapine and olanzapine can induce food craving and binge eating, however, olanzapine possibly to a greater extent. Findings on clinical efficacy and safety are in accordance with previous reports.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18004133     DOI: 10.1097/jcp.0b013e31815a8872

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  50 in total

1.  Reduced accumbens dopamine in Sprague-Dawley rats prone to overeating a fat-rich diet.

Authors:  Pedro Rada; Miriam E Bocarsly; Jessica R Barson; Bartley G Hoebel; Sarah F Leibowitz
Journal:  Physiol Behav       Date:  2010-07-16

Review 2.  Antipsychotic drugs and obesity.

Authors:  Christoph U Correll; Todd Lencz; Anil K Malhotra
Journal:  Trends Mol Med       Date:  2010-12-22       Impact factor: 11.951

Review 3.  Metformin for olanzapine-induced weight gain: a systematic review and meta-analysis.

Authors:  Samir Kumar Praharaj; Amlan Kusum Jana; Nishant Goyal; Vinod Kumar Sinha
Journal:  Br J Clin Pharmacol       Date:  2011-03       Impact factor: 4.335

4.  Treatment response to the RENEW weight loss intervention in schizophrenia: impact of intervention setting.

Authors:  Catana Brown; Jeannine Goetz; Edna Hamera; Byron Gajewski
Journal:  Schizophr Res       Date:  2014-09-26       Impact factor: 4.939

Review 5.  Neurobiology of consummatory behavior: mechanisms underlying overeating and drug use.

Authors:  Jessica R Barson; Irene Morganstern; Sarah F Leibowitz
Journal:  ILAR J       Date:  2012

Review 6.  Circuits controlling energy balance and mood: inherently intertwined or just complicated intersections?

Authors:  Chen Liu; Syann Lee; Joel K Elmquist
Journal:  Cell Metab       Date:  2014-03-13       Impact factor: 27.287

Review 7.  The effects of second-generation antipsychotics on food intake, resting energy expenditure and physical activity.

Authors:  C Cuerda; C Velasco; J Merchán-Naranjo; P García-Peris; C Arango
Journal:  Eur J Clin Nutr       Date:  2013-12-11       Impact factor: 4.016

8.  Hyperphagia and increased meal size are responsible for weight gain in rats treated sub-chronically with olanzapine.

Authors:  Nima Davoodi; Mikhail Kalinichev; Sergei A Korneev; Peter G Clifton
Journal:  Psychopharmacology (Berl)       Date:  2008-12-04       Impact factor: 4.530

9.  The impact of antipsychotic drugs on food intake and body weight and on leptin levels in blood and hypothalamic ob-r leptin receptor expression in wistar rats.

Authors:  Martina von Wilmsdorff; Marie-Luise Bouvier; Uwe Henning; Andrea Schmitt; Wolfgang Gaebel
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

10.  Treatment of obese patients with binge eating disorder using topiramate: a review.

Authors:  Paolo Leombruni; Luca Lavagnino; Secondo Fassino
Journal:  Neuropsychiatr Dis Treat       Date:  2009       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.